GlassScriptPhysician profile
Amy Li Matecki
NPI 1770571077
$543.73
in general payments reported to CMS, 2019-2025
9 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2021: $25.53 · 2024: $44.01 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $169.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.83 | 2025 | Xifaxan |
| Intuitive Surgical, INC. | $122.11 | 2019 | |
| Abbott Laboratories | $27.44 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $25.94 | 2025 | Krystexxa |
| Pharmacyclics LLC, An Abbvie Company | $25.53 | 2021 | |
| Dova Pharmaceuticals | $17.30 | 2019 | |
| Medicure Pharma INC. | $16.57 | 2024 | Zypitamag |
| Abbvie INC. | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Matecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.